Oorsprong van het eerstegraads netwerk van Clifford Brangwynne
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Nereid Therapeutics, Inc.
 Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA.
8
| Holding Company | Biotechnology | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Clifford Brangwynne via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bessemer Venture Partners LP
 Bessemer Venture Partners LP Investment ManagersFinance Bessemer Venture Partners LP seeks investment opportunities in companies primarily located in the US. The fund focuses on companies with a strong business model, experienced management teams and growth potential. It targets companies operating across a broad range of sectors such as healthcare, information systems, telecommunications, and retailing. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Consultant / Advisor | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director/Board Member | |
| E-THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Iowa State University | College/University | Doctorate Degree | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Undergraduate Degree | |
| Princeton University | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University College London | College/University | Doctorate Degree | |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Founder Private Equity Investor Private Equity Investor Private Equity Investor | |
Family Promise
 Family Promise Miscellaneous Commercial ServicesCommercial Services Family Promise is a national movement that aims to provide every family with a home, livelihood, and the opportunity to build a better future. The non-profit company is based in Summit, NJ. The organization works in over 200 communities across 43 states to ensure that families experiencing or at risk of homelessness have a safe place to call home. Family Promise delivers innovative solutions for family homelessness, including prevention, shelter, and stabilization services. Family Promise aspires to change the future for 1 million children by 2030 through its community-based programs. The organization was founded more than 30 years ago as a local initiative in Summit, NJ, and has since served over 1 million family members. | Miscellaneous Commercial Services | Director/Board Member | |
The McKnight Endowment Fund for Neuroscience
 The McKnight Endowment Fund for Neuroscience Investment Trusts/Mutual FundsMiscellaneous The McKnight Endowment Fund for Neuroscience operates as a philanthropic organization. Its services include grantmaking, coalition-building and encouragement of strategic policy reforms. The company was founded by William L. McKnight in 1989 and is headquartered in Minneapolis, MN. | Investment Trusts/Mutual Funds | Director/Board Member | |
| Millennium Predictive Medicine, Inc. | Founder | ||
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Founder | |
| ALLERGAN PLC | Pharmaceuticals: Major | Director/Board Member | |
| The Christie NHS Foundation Trust | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| VERASTEM, INC. | Biotechnology | Chairman | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member | |
| KEZAR LIFE SCIENCES, INC. | Biotechnology | Director/Board Member | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member | |
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman Chief Executive Officer | |
Excision BioTherapeutics, Inc.
 Excision BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Excision BioTherapeutics, Inc. develops gene editing therapeutics for the treatment of life-threatening disease caused by viral infections. The firm focuses on Human Immunodeficiency Virus -1 therapeutics, JC Virus and Progressive Multifocal Leukoencephalopathy, Hepatitis B virus therapeutics, and CRISPR vaccinations?. The company was founded by David Rowe, Kamel Khalili, Thomas Malcolm, and Rob Simmons in 2015 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| BIVICTRIX THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman | |
Prime Movers Lab LLC
 Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Consultant / Advisor | |
| Ambrose University | College/University | Undergraduate Degree | |
| The UCL Academy | College/University | Undergraduate Degree | |
Nine Square Therapeutics, Inc.
 Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Nine Square Therapeutics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
Initial Therapeutics Inc
 Initial Therapeutics Inc BiotechnologyHealth Technology Opal Biosciences, Inc. operates as a biotechnology company. The company is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ascidian Therapeutics, Inc.
 Ascidian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Apertor Pharmaceuticals, Inc.
 Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member President | |
Aulos Bioscience, Inc.
 Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman | |
Replicate Bioscience, Inc.
 Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Intergalactic Therapeutics, Inc.
 Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Biotechnology | Director/Board Member Founder | |
Deep Apple Therapeutics, Inc.
 Deep Apple Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Deep Apple Therapeutics, Inc. engages in a robust and promising pipeline of programs in inflammatory and immune diseases and metabolic & endocrine disorders. The company is based in New York, NY. The company was founded by Spiros Liras, John Irwin, Georgios Skiniotis, Brian Shoichet. Spiros Liras has been the CEO since incorporation. | Pharmaceuticals: Other | Chief Executive Officer | |
Mirror Biologics Inc
 Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019. | Biotechnology | Director/Board Member | |
Aethon Therapeutics, Inc.
 Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services The company, co-founded by venture capital firm Apple Tree Partners and New York University cancer researchers Shohei Koide, Ph.D., and Benjamin G. Neel, Ph.D., unites immunotherapy and targeted therapy to expand the power and promise of both approaches for people living with cancer. Aethon Therapeutics, Inc. is based in New York, NY. Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that creates neoantigens by design to transform cancer treatments into cures. The company's novel anti-drug-peptide conjugate/mhc antibodies are designed to be used in combination with targeted covalent inhibitors of ras, egfr, and other oncogenic driver mutations to mount immune attacks and selectively kill residual cancer cells, including drug-resistant "persister" cells. The company was founded by Benjamin G. Neel, Shohei Koide. The CEO is Rajesh Chopra. | Hospital/Nursing Management | Chairman Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 41 |
| Verenigd Koninkrijk | 8 |
| Canada | 2 |
| Ierland | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 9 |
| Finance | 5 |
| Commercial Services | 4 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 92 |
| Chairman | 25 |
| Independent Dir/Board Member | 18 |
| Corporate Officer/Principal | 16 |
| Chief Executive Officer | 15 |
Sterkste connecties
| Insiders | |
|---|---|
| Seth Harrison | 43 |
| Robert Hugin | 24 |
| Michael Kauffman | 24 |
| Michael Ehlers | 15 |
| Laura L. Forese | 13 |
| Rupert Vessey | 13 |
| Rajesh Chopra | 10 |
| Spiros Liras | 10 |
- Beurs
- Insiders
- Clifford Brangwynne
- Bedrijfsconnecties
